To hear about similar clinical trials, please enter your email below
Trial Title:
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
NCT ID:
NCT05805722
Condition:
Tobacco Use Cessation
Cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Single Group Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Behavioral counseling for tobacco cessation
Description:
Participants can choose to receive behavioral counseling in group v. individual format:
Group Sessions: Participants will be offered the opportunity to attend 6 weekly 60-90
minute sessions Individual Sessions: Participants will be offered the opportunity to
attend up to 12 30-45 minute sessions on a schedule mutually agreed upon between
interventionist and participant
Arm group label:
Behavioral Counseling for Tobacco Cessation
Summary:
The purpose of this research study is to learn how best to incorporate tobacco cessation
treatment into clinical care for cancer patients, survivors, and caregivers.
Detailed description:
The goal of this study is to generate knowledge regarding the feasibility and
acceptability of integrating tobacco cessation treatment into clinical care for cancer
patients, survivors, and caregivers. The evidence base regarding tobacco treatment is
solid: pharmacology (nicotine replacement therapy (and/or), bupropion, or varenicline) in
combination with behavioral counseling yields the best results with respect to cessation
rates. What remains unclear is how best to offer and implement this comprehensive
treatment in the context of a cancer center-especially in a patient population facing
social determinants of health that may not be in favor of tobacco cessation. Thus, in
this study, the investigators are offering the "gold standard" tobacco treatment and
assessing feasibility and acceptability of these procedures in order to inform future
efforts to optimize treatment delivery for this unique population and setting. The
intervention for this protocol was approved for standard of care use.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with study procedures and availability for the duration
of the study
- Have a documented history of cancer of any type, whether active or in remission
- Identify as a current or recently-quit tobacco user
Exclusion Criteria:
- Not a VCUHealth patient
- Non English-speaking
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Virginia Commonwealth University
Address:
City:
Richmond
Zip:
23298
Country:
United States
Start date:
April 12, 2023
Completion date:
September 30, 2026
Lead sponsor:
Agency:
Virginia Commonwealth University
Agency class:
Other
Source:
Virginia Commonwealth University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05805722
